Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
Metab Brain Dis ; 38(2): 657-670, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36409382

ABSTRACT

The aim was to investigate the association between plasma levels of cellular adhesion molecules (CAMs) and risk factors, subtypes, severity and short-term mortality of acute ischemic stroke (IS), and to identify a panel of biomarkers to predict short-term mortality after IS. The prospective study evaluated 132 IS patients within 24 h of their hospital admission. The baseline IS severity was assessed using the National Institutes Health Stroke Scale (NIHSS) and categorized as mild (NIHSS < 5), moderate (NIHSS 5-14) and severe (NIHSS ≥ 15). After three-month follow-up, the disability was assessed using the modified Rankin Scale (mRS); moreover, the patients were classified as survivors and non-survivors. Baseline inflammatory and anti-inflammatory cytokines and soluble CAMs were evaluated. Twenty-nine (21.9%) IS patients were non-survivors and showed higher NIHSS and soluble vascular cellular adhesion molecule 1 (sVCAM-1) than the survivors. The sVCAM-1 levels positively correlated with age, homocysteine, severity, and disability. The model #3 combining sVCAM-1 and NIHSS showed better results to predict short-term mortality with an area under the curve receiving operating characteristics (AUC/ROC) of 0.8841 [95% confidence interval (CI): 0.795-0.941] than the models with sVCAM-1 and NIHSS alone, with positive predictive value of 68.0%, negative predictive value of 91.3%, and accuracy of 86.5%. In conclusion, the combined model with baseline severity of IS and sVCAM-1 levels can early predict the prognosis of IS patients who may benefit with therapeutic measures of personalized therapy that taken into account these biomarkers. Moreover, this result suggests that VCAM-1 might be a potential target for the therapeutic strategies in IS.


Subject(s)
Brain Ischemia , Ischemic Stroke , Stroke , Humans , Stroke/diagnosis , Vascular Cell Adhesion Molecule-1 , Ischemic Stroke/complications , Brain Ischemia/complications , Prospective Studies , Biomarkers
2.
Clin Exp Med ; 22(1): 111-123, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34120242

ABSTRACT

Some clinical, imaging, and laboratory biomarkers have been identified as predictors of prognosis of acute ischemic stroke (IS). The aim of this study was to evaluate the prognostic validity of a combination of clinical, imaging, and laboratory biomarkers in predicting 1-year mortality of IS. We evaluated 103 patients with IS within 24 h of their hospital admission and assessed demographic data, IS severity using the National Institutes of Health Stroke Scale (NIHSS), carotid intima-media thickness (cIMT), and degree of stenosis, as well as laboratory variables including immune-inflammatory, coagulation, and endothelial dysfunction biomarkers. The IS patients were categorized as survivors and non-survivors 1 year after admission. Non-survivors showed higher NIHSS and cIMT values, lower antithrombin, Protein C, platelet counts, and albumin, and higher Factor VIII, von Willebrand Factor (vWF), white blood cells, tumor necrosis factor (TNF)-α, interleukin (IL)-10, high-sensitivity C-reactive protein (hsCRP), and vascular cellular adhesion molecule 1 (VCAM-1) than survivors. Neural network models separated non-survivors from survivors using NIHSS, cIMT, age, IL-6, TNF-α, hsCRP, Protein C, Protein S, vWF, and platelet endothelial cell adhesion molecule 1 (PECAM-1) with an area under the receiving operating characteristics curve (AUC/ROC) of 0.975, cross-validated accuracy of 93.3%, sensitivity of 100% and specificity of 85.7%. In conclusion, imaging, immune-inflammatory, and coagulation biomarkers add predictive information to the NIHSS clinical score and these biomarkers in combination may act as predictors of 1-year mortality after IS. An early prediction of IS outcome is important for personalized therapeutic strategies that may improve the outcome of IS.


Subject(s)
Ischemic Stroke , Stroke , Biomarkers , Carotid Intima-Media Thickness , Humans , Machine Learning , Prognosis , Stroke/diagnostic imaging
3.
Metab Brain Dis ; 36(7): 1747-1761, 2021 10.
Article in English | MEDLINE | ID: mdl-34347209

ABSTRACT

Acute ischemic stroke (IS) is one of the leading causes of morbidity, functional disability and mortality worldwide. The objective was to evaluate IS risk factors and imaging variables as predictors of short-term disability and mortality in IS. Consecutive 106 IS patients were enrolled. We examined the accuracy of IS severity using the National Institutes of Health Stroke Scale (NIHSS), carotid intima-media thickness (cIMT) and carotid stenosis (both assessed using ultrasonography with doppler) predicting IS outcome assessed with the modified Rankin scale (mRS) three months after hospital admission. Poor prognosis (mRS ≥ 3) at three months was predicted by carotid stenosis (≥ 50%), type 2 diabetes mellitus and NIHSS with an accuracy of 85.2% (sensitivity: 90.2%; specificity: 81.8%). The mRS score at three months was strongly predicted by NIHSS (ß = 0.709, p < 0.001). Short-term mortality was strongly predicted using a neural network model with cIMT (≥ 1.0 mm versus < 1.0 mm), NIHSS and age, yielding an area under the receiving operator characteristic curve of 0.977 and an accuracy of 94.7% (sensitivity: 100.0%; specificity: 90.9%). High NIHSS (≥ 15) and cIMT (≥ 1.0 mm) increased the probability of dying with hazard ratios of 7.62 and 3.23, respectively. Baseline NIHSS was significantly predicted by the combined effects of age, large artery atherosclerosis stroke, sex, cIMT, body mass index, and smoking. In conclusion, high values of cIMT and NIHSS at admission strongly predict short-term functional impairment as well as mortality three months after IS, underscoring the importance of those measurements to predict clinical IS outcome.


Subject(s)
Brain Ischemia , Diabetes Mellitus, Type 2 , Ischemic Stroke , Stroke , Brain Ischemia/diagnostic imaging , Carotid Intima-Media Thickness , Diabetes Mellitus, Type 2/complications , Humans , Ischemic Stroke/diagnostic imaging , Machine Learning , Risk Factors , Severity of Illness Index , Stroke/diagnostic imaging
4.
Metab Brain Dis ; 30(6): 1417-28, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26359121

ABSTRACT

The aim of this study was to evaluate the association between inflammatory and metabolic markers and short-time outcome with acute ischemic stroke subtypes. A total of 121 patients was classified according to TOAST criteria, such as large artery atherosclerosis (LAAS), lacunar infarct (LAC), cardioembolic infarct (CEI), other determined etiology (ODE), and undetermined etiology (UDE). The functional impairment was evaluated within the first eight hours of stroke and the outcome after three-month follow-up using the modified Rankin Scale. Blood samples were obtained up to 24 h of stroke. Compared with 96 controls, patients with LAAS, CEI, and LAC subtypes showed higher levels of white blood cells, high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), metalloproteinase 9 (MMP-9), glucose, and iron (p < 0.05); and lower high-density lipoprotein cholesterol (HDL-C) (p < 0.0001); platelets, insulin, insulin resistance, and homocysteine were higher in LAC (p < 0.0001); ferritin was higher in LAAS (p < 0.0001); and total cholesterol (TC) was lower in LAAS and CEI (p < 0.01). When stroke subtypes were compared, insulin was higher in LAAS vs. LAC and in LAC vs. CEI (p < 0.05); and TC was lower in LAAS vs. LAC (p < 0.05). Outcome and rate of mortality after three-month were higher in LAAS vs. LAC (p < 0.001 and p = 0.0391 respectively). The results underscored the important role of the inflammatory response and metabolic changes in the pathogenesis of ischemic stroke subtypes that might be considered on the initial evaluation of stroke patients to identify those that could benefit with individualized therapeutic strategies that taken into account these markers after acute ischemic event.


Subject(s)
Brain Ischemia/metabolism , Brain Ischemia/pathology , Inflammation/metabolism , Inflammation/pathology , Stroke/metabolism , Stroke/pathology , Adult , Aged , Anthropometry , Biomarkers , Brain Ischemia/classification , Brazil , C-Reactive Protein/analysis , Case-Control Studies , Cerebral Infarction/pathology , Female , Humans , Interleukin-6/blood , Male , Matrix Metalloproteinase 9/blood , Middle Aged , Socioeconomic Factors , Stroke/classification , Treatment Outcome , Young Adult
5.
J. bras. neurocir ; 24(3): 194-200, 2013.
Article in English | LILACS | ID: lil-726506

ABSTRACT

Objetivos: O risco de complicação de angiografia cerebral tem sido constantemente foco de atenção. O objetivo deste estudofoi avaliar o resultado de angiografia cerebral realizada nos primeiros 30 meses de treinamento operacional em um serviço deneurocirurgia endovascular em um hospital universitário. Métodos: Foi realizado um estudo retrospectivo para avaliação de129 resultados de angiografia cerebral digital realizada em 91 pacientes em um hospital universitário da região sul do Brasil.Resultados: A taxa de complicação foi de 2 /129 (1,55%); destas, um (0,77%) paciente apresentou complicação transitória(hematoma no local da punção), e outro (0,77%) apresentou uma complicação permanente com óbito devido à associação entrecoagulação na artéria média cerebral e complicações do trauma inicial. Conclusão: A taxa de complicação da angiografiacerebral observada neste estudo foi baixa (1,75%) e reafirma seu risco reduzido quando realizada em um serviço de neurocirurgiamesmo com profissionais médicos em treinamento.


Subject(s)
Cerebral Angiography , Neurosurgery , Subarachnoid Hemorrhage , Mentoring
SELECTION OF CITATIONS
SEARCH DETAIL
...